Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Associate Professor Liam Burke: What Netflix Buying Warner Bros Could Mean for Cinema
Netflix’s move to buy Warner Bros has raised questions about the future of cinema. Associate Professor Liam Burke explains the ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:49 — 13.5MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Christmas Songs Get Stuck in Our Heads
Christmas music triggers instant memories, emotions and associations, often within seconds of hearing it. Associate Professor Lauren Rosewarne explains why ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:47 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Lee Knight: Preventing Domestic Violence Before It Happens
A world-first Australian trial is exploring whether treating impulsivity could help prevent domestic and family violence before harm occurs. Lee ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:24 — 17.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS